Back
Direxion Daily S&P500® Bull 3X ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
67
SPXL
Direxion Daily S&P500® Bull 3X ETF
Last Price:
147.78
Seasonality Move:
8.46%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
158.06
Seasonality Move:
18.65%
Buy
67
Direxion Daily S&P500® Bull 3X ETF (SPXL)
is a Buy
Is Direxion Daily S&P500® Bull 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily S&P500® Bull 3X ETF [SPXL] share price is $147.93. The Score for SPXL is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- SPXL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $157.96. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SPXL Stock Price Chart
What is Direxion Daily S&P500® Bull 3X ETF's stock price today?
-
The Direxion Daily S&P500® Bull 3X ETF share price today is $147.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPXL is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $157.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
SPXL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.23 | Buy |
Relative Strength Index (14 RSI): | 69.1 | Buy |
Chaikin Money Flow: | 931509 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (134.38 - 146.36) | Buy |
Bollinger Bands (100): | (119.47 - 137.97) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.07 | Buy |
Relative Strength Index (14 RSI): | 68.93 | Buy |
Chaikin Money Flow: | 909555 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (113.85 - 144.93) | Buy |
Bollinger Bands (100): | (118.68 - 136.96) | Buy |
SPXL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 147.4 | Buy |
20-day SMA: | 141.87 | Buy |
50-day SMA: | 132.45 | Buy |
200-day SMA: | 109.87 | Buy |
8-day EMA: | 146.48 | Buy |
20-day EMA: | 142.75 | Buy |
50-day EMA: | 135.85 | Buy |
200-day EMA: | 115.57 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 144.42 | Buy |
20-day SMA: | 131.3 | Buy |
50-day SMA: | 128.76 | Buy |
200-day SMA: | 115.64 | Buy |
8-day EMA: | 148.13 | Buy |
20-day EMA: | 137 | Buy |
50-day EMA: | 130.51 | Buy |
200-day EMA: | 121.04 | Buy |
Direxion Daily S&P500® Bull 3X ETF Earnings Growth & SPXL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
Direxion Daily S&P500® Bull 3X ETF Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |